Latest Unsolved problems in neuroscience Stories
People with Parkinson's disease performed markedly better on a test of working memory after a night's sleep, and sleep disorders can interfere with that benefit.
Sanford-Burnham researchers discover that an enzyme known for generating toxic brain plaques in Alzheimer's disease also causes additional memory and cognitive deficits via a separate mechanism
The ALS Association, Upstate New York Chapter, announces its annual Walk to Defeat ALS® on Sunday, August 12, 2012 at Otsiningo Park, Binghamton, N.Y.
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease.
In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease.
Researchers recently found that a particular type of yoga that allows participants to practice brief meditation on a daily basis will help decrease stress for people who take care of patients with Alzheimer’s and dementia.
More Images (2 images) »